Purchase Order AG7B31P10AB69

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...

A&G Pharmaceutical, Inc. (doing business as Precision Antibody) was awarded a $12,126.75 firm fixed-price purchase order by a civilian federal agency with operations in the Pacific West Area for peptide synthesis services supporting antibody development. The contract, awarded on September 24, 2019, with an ultimate completion date of December 24, 2019, covers the synthesis of two peptide sequences on a per-amino-acid basis. The work will be performed in Parlier, California. No set-aside...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $1,725,000.00 definitive, firm-fixed-price contract to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) to provide 3.5 kilograms of current Good Manufacturing Practice (GMP) synthetic Preimplantation Factor (sPIF) peptide. The contract, which does not have a set-aside designation, was awarded on August 14, 2018 with a completion date...

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for the provision of custom HIV peptides. The contract has a ceiling value of $12,801.20 and an ultimate completion date of September 1, 2017. Peptide 2.0 Inc. is a minority-owned, for-profit business that specializes in custom peptide synthesis and...

This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Peprotech Inc., a privately-owned biotechnology company. The $4,205 contract is for the delivery of drugs and biologicals, with a performance period ending on September 16, 2012. Peprotech Inc. is a manufacturer of cytokines and other biological products, and has received several prior federal contract awards from...

Peprotech Inc. was awarded an indefinite delivery/indefinite quantity (IDIQ) blanket purchase agreement (BPA) call by the National Institutes of Health (NIH) to provide biological materials and blood/blood products in support of NIH's biomedical research programs. As the prime contractor, Peprotech will deliver these commodities from its Bethesda, Maryland facility on an as-needed basis over an open-ended period of performance beginning in December 2008. The contract pricing structure utilizes...

This is a firm fixed-price Blanket Purchase Agreement (BPA) contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Peprotech Inc., a private biotechnology company that develops and manufactures cytokine products. The contract, with a ceiling value of $5,402.00, is for the delivery of biological materials to facilitate NIH's research efforts. Peprotech Inc. has received several previous federal...

The U.S. government awarded a $5,770 firm fixed price purchase order to Vivitide LLC (doing business as New England Peptide) on May 31, 2016, for the delivery of 3X affinity purified antibody packages including Oncorhyncin II, Beta Defensin, and Hepcidin, with dry ice included for shipment. The contract was completed on June 2, 2016, and performance took place in Gardner, Massachusetts. This was a civilian acquisition with no small business set-aside designation. Vivitide LLC is a specialized...

This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Peprotech Inc., a privately-owned biotechnology company that develops and manufactures cytokines products. The contract is a Blanket Purchase Agreement (BPA) with a potential value of $100 million for the delivery of biological materials to facilitate NIH's research efforts. The contract has no set-aside designation....